semaglutide approved for obesity Current Strategies in Managing Semaglutide vs Tirzepatide for Weight

Both medications are injectables designed to support weight loss efforts, but their mechanisms and effectiveness vary, which is why its important to work with our providers to determine the best approach tailored to your unique needs

Semaglutides safety profile is characterized mainly by gastrointestinal intolerance, with nausea being common and also the predominant finding in reported overdoses up to 4 mg

Vive Ageless Weight Loss Center provides a detailed Q&A comparing Zepbound, Semaglutide GLP-1, and Wegovy, highlighting how each works and what results to expect

Y.KwonJ

Common gastrointestinal effects of Wegovy include (according to the UK SmPC): Nausea (reported in up to 44% of patients) Diarrhoea (approximately 30% of patients) Vomiting (24% of patients) Constipation (24% of patients) Abdominal pain and bloating Many antibiotics, particularly broad-spectrum agents , can disrupt the normal gut microbiome, leading to diarrhoea, abdominal discomfort, nausea, and occasionally more serious complications such as Clostridioides difficile infection

This label certifies natural formulations, from the selection of active ingredients to excipients, free from artificial colors and flavors, aspartame, titanium dioxide, GMOs, nanoparticles, irradiation, colloidal silica, preservatives, and animal testing, and manufactured in Europe